ko	pathway	ratio_in_study	ratio_in_pop	p_value
ko04621	NOD-like receptor signaling pathway	13/116	157/7206	1.20176373817e-06
ko04064	NF-kappa B signaling pathway	10/116	96/7206	2.79069748939e-06
ko04217	Necroptosis	12/116	178/7206	2.61768199815e-05
ko04660	T cell receptor signaling pathway	10/116	124/7206	2.76776350662e-05
ko04380	Osteoclast differentiation	10/116	134/7206	5.40512404338e-05
ko05161	Hepatitis B	11/116	173/7206	9.82982869968e-05
ko05162	Measles	9/116	120/7206	0.000124657890249
ko04668	TNF signaling pathway	9/116	120/7206	0.000124657890249
ko04658	Th1 and Th2 cell differentiation	8/116	96/7206	0.00014432333392
ko04620	Toll-like receptor signaling pathway	8/116	100/7206	0.00019200894646
ko05167	Kaposi's sarcoma-associated herpesvirus infection	11/116	191/7206	0.000236281426982
ko04659	Th17 cell differentiation	8/116	106/7206	0.000287237968698
ko05212	Pancreatic cancer	7/116	83/7206	0.000353410224794
ko05418	Fluid shear stress and atherosclerosis	10/116	173/7206	0.000445085919684
ko04662	B cell receptor signaling pathway	7/116	88/7206	0.000505814070452
ko00511	Other glycan degradation	4/116	26/7206	0.000724910217331
ko05164	Influenza A	9/116	167/7206	0.00141962683225
ko04015	Rap1 signaling pathway	12/116	278/7206	0.00163933114781
ko05321	Inflammatory bowel disease (IBD)	5/116	56/7206	0.00196851893098
ko05215	Prostate cancer	7/116	111/7206	0.00199805618426
ko05200	Pathways in cancer	17/116	492/7206	0.00237934924602
ko04210	Apoptosis	9/116	180/7206	0.00238047253944
ko05221	Acute myeloid leukemia	5/116	63/7206	0.00331350306881
ko04623	Cytosolic DNA-sensing pathway	4/116	41/7206	0.0040794664186
ko00531	Glycosaminoglycan degradation	3/116	23/7206	0.00569193075881
ko01521	EGFR tyrosine kinase inhibitor resistance	6/116	106/7206	0.0070656710436
ko05166	HTLV-I infection	11/116	292/7206	0.00715693694909
ko04218	Cellular senescence	8/116	177/7206	0.00754712096497
ko04070	Phosphatidylinositol signaling system	6/116	112/7206	0.00917064182527
ko00590	Arachidonic acid metabolism	4/116	52/7206	0.00952731861063
ko04151	PI3K-Akt signaling pathway	13/116	390/7206	0.0111142873908
ko05160	Hepatitis C	7/116	153/7206	0.0114895331641
ko04060	Cytokine-cytokine receptor interaction	8/116	191/7206	0.0116712016336
ko05220	Chronic myeloid leukemia	5/116	85/7206	0.0117026973786
ko04657	IL-17 signaling pathway	5/116	87/7206	0.0128543676553
ko00562	Inositol phosphate metabolism	5/116	89/7206	0.0140805631721
ko05222	Small cell lung cancer	5/116	89/7206	0.0140805631721
ko04014	Ras signaling pathway	10/116	279/7206	0.0141444734502
ko05145	Toxoplasmosis	6/116	126/7206	0.0157657316324
ko04611	Platelet activation	7/116	163/7206	0.0158439536441
ko00944	Flavone and flavonol biosynthesis	1/116	1/7206	0.0160976963641
ko04622	RIG-I-like receptor signaling pathway	4/116	62/7206	0.0173737341136
ko05169	Epstein-Barr virus infection	8/116	206/7206	0.0177286672338
ko00600	Sphingolipid metabolism	4/116	63/7206	0.0183269701167
ko04630	Jak-STAT signaling pathway	6/116	132/7206	0.019404483793
ko05132	Salmonella infection	5/116	98/7206	0.0205719851534
ko05223	Non-small cell lung cancer	4/116	66/7206	0.0213795696271
ko00564	Glycerophospholipid metabolism	5/116	99/7206	0.0213959875119
ko04933	AGE-RAGE signaling pathway in diabetic complications	6/116	135/7206	0.021423221576
ko04931	Insulin resistance	6/116	137/7206	0.0228455517842
ko05168	Herpes simplex infection	7/116	182/7206	0.0271458168332
ko00565	Ether lipid metabolism	3/116	42/7206	0.0296053251436
ko05140	Leishmaniasis	4/116	75/7206	0.0323262595952
ko04142	Lysosome	6/116	151/7206	0.0346063296797
ko04370	VEGF signaling pathway	4/116	77/7206	0.0351317668806
ko05412	Arrhythmogenic right ventricular cardiomyopathy (ARVC)	4/116	79/7206	0.0380746663017
ko04610	Complement and coagulation cascades	4/116	79/7206	0.0380746663017
ko04072	Phospholipase D signaling pathway	7/116	197/7206	0.0392612412698
ko04624	Toll and Imd signaling pathway	3/116	49/7206	0.0438478035634
ko05203	Viral carcinogenesis	9/116	277/7206	0.0442970762353
ko04066	HIF-1 signaling pathway	5/116	123/7206	0.0478971781628